January 22, 2014
Yet another Japanese clinical trial on Diovan (valsartan), dubbed SMART, has been retracted from a renowned medical journal, the initiator of the study said – the latest development in a scandal surrounding Novartis Pharma’s best-selling blood pressure drug. Shiga University...read more